fosfomycin (Contepo): FDA status

Approved Approved Nov 4, 2025. Indication: complicated urinary tract infection including acute pyelonephritis. Company: Meitheal Pharmaceuticals.

Regulatory history

All products in the FDA Tracker

Loading today's edition…